Cargando…

Palbociclib Enhances Migration and Invasion of Cancer Cells via Senescence-Associated Secretory Phenotype-Related CCL5 in Non-Small-Cell Lung Cancer

Palbociclib is the first CDK4/6 inhibitor approved by FDA and has been studied in many types of cancer. However, some studies showed that it could induce epithelial-mesenchymal transition (EMT) of cancer cells. To test the effect of palbociclib on non-small-cell lung cancer (NSCLC) cells, we treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Pengzhou, Yang, Xin, Zhang, Yingying, Dong, Huiling, Liu, Xiangchen, Xu, Xiaoqin, Zhang, Xinri, Shi, Yiwei, Hou, Mingxia, Song, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175017/ https://www.ncbi.nlm.nih.gov/pubmed/37181790 http://dx.doi.org/10.1155/2022/2260625

Ejemplares similares

Cell senescence, the senescence-associated secretory phenotype, and cancers
por: Langhi Prata, Larissa G. P., et al.
Publicado: (2023)

Palbociclib induces cell senescence and apoptosis of gastric cancer cells by inhibiting the Notch pathway
por: Bi, Hengtai, et al.
Publicado: (2021)

Cyclovirobuxine D inhibits growth and progression of non-small cell lung cancer cells by suppressing the KIF11-CDC25C-CDK1-CyclinB1 G(2)/M phase transition regulatory network and the NFκB/JNK signaling pathway
por: Xue, Ting, et al.
Publicado: (2023)

Transcriptome Analysis of Ivosidenib-Mediated Inhibitory Functions on Non-Small Cell Lung Cancer
por: Wu, Juan, et al.
Publicado: (2021)

Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells
por: Cahu, J, et al.
Publicado: (2012)

Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy
por: Saleh, Tareq, et al.
Publicado: (2018)

Systematic Transcriptome Analysis Reveals the Inhibitory Function of Cinnamaldehyde in Non-Small Cell Lung Cancer
por: Chen, Ru, et al.
Publicado: (2021)

Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
por: Kumari, Ruchi, et al.
Publicado: (2021)

Immunotherapeutic approach to reduce senescent cells and alleviate senescence‐associated secretory phenotype in mice
por: Shrestha, Niraj, et al.
Publicado: (2023)

Palbociclib Induces Senescence in Melanoma and Breast Cancer Cells and Leads to Additive Growth Arrest in Combination With Irradiation
por: Jost, Tina, et al.
Publicado: (2021)

The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer
por: Higashiguchi, Masaya, et al.
Publicado: (2023)

PIF1 Promotes Autophagy to Inhibit Chronic Hypoxia Induced Apoptosis of Pulmonary Artery Endothelial Cells
por: Zhao, Yujing, et al.
Publicado: (2023)

Colchicine Protects against Ethanol-Induced Senescence and Senescence-Associated Secretory Phenotype in Endothelial Cells
por: Zhou, Huakang, et al.
Publicado: (2023)

Senescence-activated enhancer landscape orchestrates the senescence-associated secretory phenotype in murine fibroblasts
por: Guan, Yiting, et al.
Publicado: (2020)

Cellular senescence and senescence‐associated secretory phenotype via the cGAS‐STING signaling pathway in cancer
por: Loo, Tze Mun, et al.
Publicado: (2019)

Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease
por: Wang, Wen-Juan, et al.
Publicado: (2017)

Senescence-Associated Secretory Phenotype Determines Survival and Therapeutic Response in Cervical Cancer
por: Purohit, Sharad, et al.
Publicado: (2020)

Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer
por: Banerjee, Priyanka, et al.
Publicado: (2021)

N-Acetyltransferase 10 Promotes Micronuclei Formation to Activate the Senescence-Associated Secretory Phenotype Machinery in Colorectal Cancer Cells
por: Cao, Yanan, et al.
Publicado: (2020)

From cell senescence to age-related diseases: differential mechanisms of action of senescence-associated secretory phenotypes
por: Byun, Hae-Ok, et al.
Publicado: (2015)

Mettl14-driven senescence-associated secretory phenotype facilitates somatic cell reprogramming
por: Xi, Chenxiang, et al.
Publicado: (2022)

Insight into the role of PIKK family members and NF-кB in DNAdamage-induced senescence and senescence-associated secretory phenotype of colon cancer cells
por: Strzeszewska, Anna, et al.
Publicado: (2018)

Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancer
por: Chu, Liping, et al.
Publicado: (2022)

Ceria Nanoparticles Alleviated Osteoarthritis through Attenuating Senescence and Senescence-Associated Secretory Phenotype in Synoviocytes
por: Ren, Xunshan, et al.
Publicado: (2023)

In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers
por: Samakkarnthai, Parinya, et al.
Publicado: (2023)

MLL1 is essential for the senescence-associated secretory phenotype
por: Capell, Brian C., et al.
Publicado: (2016)

The Role of Senescence-Associated Secretory Phenotype in Bone Loss
por: Zhu, Runjiu, et al.
Publicado: (2022)

The senescence-associated secretory phenotype induces neuroendocrine transdifferentiation
por: Huna, Anda, et al.
Publicado: (2023)

Senescent Endothelial Cells Sustain Their Senescence-Associated Secretory Phenotype (SASP) through Enhanced Fatty Acid Oxidation
por: Giuliani, Angelica, et al.
Publicado: (2023)

CCL18 Knockdown Suppresses Cell Growth and Migration in Thyroid Cancer
por: Sun, Caixia, et al.
Publicado: (2022)

Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB
por: Camorani, Simona, et al.
Publicado: (2018)

Palbociclib-Induced Cellular Senescence Is Modulated by the mTOR Complex 1 and Autophagy
por: Cayo, Angel, et al.
Publicado: (2023)

Palbociclib in the treatment of recurrent ovarian cancer
por: Lee, Dai Wee, et al.
Publicado: (2020)

Palbociclib in breast cancer neoadjuvant setting
por: Duarte, Sílvia Alexandra Cabral, et al.
Publicado: (2021)

Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence
por: Pandey, Kamal, et al.
Publicado: (2020)

Effects of senescent secretory phenotype acquisition on human retinal pigment epithelial stem cells
por: Lazzarini, Raffaella, et al.
Publicado: (2018)

Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2‐independent mechanism
por: Wang, Rong, et al.
Publicado: (2017)

Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation
por: Khavinson, Vladimir, et al.
Publicado: (2022)

Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway
por: Sun, Xuerong, et al.
Publicado: (2018)

Radiation-Induced Senescence Reprograms Secretory and Metabolic Pathways in Colon Cancer HCT-116 Cells
por: Nagineni, Chandrasekharam N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_77vo18giufn2ftic57fa0dom3j